![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Fuller Peter
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.15, Iss.3, 2006-03, pp. : 201-203
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Eplerenone, a New Selective Aldosterone Blocker
Current Pharmaceutical Design, Vol. 9, Iss. 13, 2003-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Gros Robert Ding Qingming Davis Mark Shaikh Rasha Liu Bonan Chorazyczewski Jozef Pickering J. Geoffrey Feldman Ross D.
Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 9, 2011-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Aldosterone Receptor Antagonists for Hypertension: What Do They Offer?
Drugs, Vol. 63, Iss. 19, 2003-01 ,pp. :